APA (7th ed.) Citation
Li, S., Meng, W., Zhang, J., Xie, X., Hao, C., Jia, Y., & Tong, Z. (2020). A randomized controlled Phase II trial of vinorelbine plus capecitabine versus docetaxel plus capecitabine in anthracycline-pretreated women with metastatic breast cancer. Journal of Cancer Research & Therapeutics, 16(5), 1069-1077.
Chicago Style (17th ed.) Citation
Li, Shufen, Wenjing Meng, Jibo Zhang, Xiaojuan Xie, Chunfang Hao, Yongsheng Jia, and Zhongsheng Tong. "A Randomized Controlled Phase II Trial of Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women with Metastatic Breast Cancer." Journal of Cancer Research & Therapeutics 16, no. 5 (2020): 1069-1077.
MLA (9th ed.) Citation
Li, Shufen, et al. "A Randomized Controlled Phase II Trial of Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women with Metastatic Breast Cancer." Journal of Cancer Research & Therapeutics, vol. 16, no. 5, 2020, pp. 1069-1077.
Warning: These citations may not always be 100% accurate.